Lahore: Highnoon Laboratories Limited announced its financial results for the year ending December 31, 2024, revealing a significant increase in profit and a substantial cash dividend recommendation. The board of directors, during their meeting on March 26, 2025, approved a 400% cash dividend while foregoing bonus and right shares.

The company reported a profit of 3.25 billion rupees for the year 2024, up from 2.40 billion rupees in 2023, reflecting robust financial performance. Total comprehensive income for the year stood at 3.21 billion rupees, compared to 2.99 billion rupees in the previous year. The Annual General Meeting is scheduled for April 29, 2025, at the company’s registered office in Lahore.

According to information available from the Pakistan Stock Exchange (PSX), the consolidated profit for 2024 reached 3.39 billion rupees, a rise from 2.45 billion rupees in 2023. The total comprehensive income for the consolidated statement was recorded at 3.35 billion rupees, compared to 3.22 billion rupees in the prior year.

Revaluation surplus on property, plant, and equipment along with deferred tax adjustments contributed to the overall financial figures. Despite a remeasurement loss on gratuity, the overall comprehensive income highlighted a positive trend. The share transfer books will be closed from April 22 to April 29, 2025, for entitlement purposes and participation in the AGM.